ArticleScientific reports2025
Impact of HCV elimination on metabolism markers in people living with HIV.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Coinfection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) alter lipid and glucose metabolism mediated by cytokines release. Our aim was to assess the evolution in metabolic plasmatic markers of people living with HIV (PLHIV) after HCV elimination either spontaneously or with direct active antivirals (DAAs). Multicenter prospective study of 116 HIV patients: i) HCV chronically infected patients (CHC) = 45; ii) Spontaneous clarifiers (SC) = 36; and iii) HIV control group = 35. HCV-exposed patients were all studied at baseline and 48 weeks after achieving sustained virological response (SVR). Plasma levels of 14 metabolic biomarkers were measured. Differences between groups were evaluated by statistical methods. At baseline, CHC patients showed higher levels of adiponectin, NGAL and sICAM-1, than the control group. After achieving SVR, the CHC group showed a significant decrease in the 3 cytokines that were increased at baseline: adiponectin, NGAL and sICAM. In contrast, there was an increase in cortisol. After the end of the follow-up CHC showed normalization of all measured markers that were increased at baseline. Any changes were observed in the same follow-up period for the SC group. Chronically coinfected HIV + /HCV + patients showed altered levels in lipid and glucose metabolism compared to HIV monoinfected subjects and spontaneous clearers. The elimination of chronic HCV infection by DAAs normalized the metabolism profile except for cortisol that remains increased after reaching RSV compared to levels observed in the HCV-/HIV + group. Spontaneous clarification of HCV did not modify metabolism biomarkers in these patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.